Literature DB >> 10535412

Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy.

M E Caplin1, P Clarke, S Grimes, A P Dhillon, K Khan, K Savage, J Lewin, D Michaeli, R E Pounder, S A Watson.   

Abstract

The CCK-B/gastrin receptor has been characterised in both normal and tumour tissues. Endocytosis of the CCK-B/gastrin receptor has recently been demonstrated and this has similarly been described for other peptide receptors. In addition, ligand and ligand-receptor translocation to the nucleus has been demonstrated for other peptides. The aim of this study was to identify the sites of expression of the CCK-B/gastrin receptor in the known CCK-B/gastrin receptor bearing pancreatic acinar AR42J cells. The specificity of the CCK-B/gastrin receptor antibody (alpha-CCKBR-Ser antibody) was demonstrated by inhibition ELISA studies, radioligand inhibition studies and immunofluorescence binding studies on AR42J cells. Western blotting and immunogold electron microscopy techniques were used to identify the receptor in AR42J cell preparations. The affinity purified alpha-CCKBR-Ser antibody was shown to be specific for the CCK-B/gastrin receptor. The receptor was expressed on the cell membrane, in the cytoplasm and within the nucleus. Isoforms of the receptor protein identified in extra-nuclear and nuclear extracts ranged in molecular weight from 58 to 66 kDa. We conclude that the CCK-B/gastrin receptor is not only expressed on the cell membrane, but also in the cytoplasm and nucleus of AR42J pancreatic acinar cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535412     DOI: 10.1016/s0167-0115(99)00071-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

1.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

2.  G and D cells in rat antral mucosa: an immunoelectron microscopic study.

Authors:  Feng-Peng Sun; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Radiopharmaceutical Formulation and Preclinical Testing of 68Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial.

Authors:  Anton A Hörmann; Maximilian Klingler; Christine Rangger; Christian Mair; Clemens Decristoforo; Christian Uprimny; Irene J Virgolini; Elisabeth von Guggenberg
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.